Accuray (ARAY) Amortization of Deferred Charges (2012 - 2026)
Accuray's (ARAY) quarterly Amortization of Deferred Charges came in at $2.3 million in Q1 2026, up 190.99% year-on-year from $799000.0 in Q1 2025, and up 43.61% quarter-over-quarter from $1.6 million in Q4 2025.
Accuray (ARAY) Amortization of Deferred Charges (2012 - 2026) Analysis & Trends
Accuray's Amortization of Deferred Charges history runs 15 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 190.99% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $6.6 million, a 226.04% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 50.68% from the prior year.
- Amortization of Deferred Charges grew to $2.3 million in Q1 2026 per ARAY's latest filing, from $1.6 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $2.3 million in Q1 2026 and bottomed at $219000.0 in Q3 2022.
- The 5-year median for Amortization of Deferred Charges is $594000.0 (2022), against an average of $776307.7.
- Across the five-year window, Amortization of Deferred Charges plunged 45.3% in 2022 and soared 650.0% in 2025, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $228000.0 in 2022, then climbed by 3.95% to $237000.0 in 2023, then advanced by 16.03% to $275000.0 in 2024, then surged by 488.73% to $1.6 million in 2025, then jumped by 43.61% to $2.3 million in 2026.
- Per Business Quant, the three latest ARAY Amortization of Deferred Charges figures stand at $2.3 million (Q1 2026), $1.6 million (Q4 2025), and $1.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.00 Bn | 175.71 Bn | 6.27 Bn |
| 2 | Stryker | 128.69 Bn | 125.81 Bn | 3.81 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.97 Bn | 44.30 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.00 Bn | 1.98 Bn |
| 7 | Dexcom | 28.21 Bn | 27.09 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn |
| 10 | Accuray | 27,980.83 | -38.51 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.33 Mn |
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | 1.62 Mn |
| Dec 31, 2025 | 1.62 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 799,000.00 |
| Mar 31, 2025 | 799,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Sep 30, 2024 | 254,000.00 |
| Sep 30, 2024 | 254,000.00 |
| Mar 31, 2024 | 711,000.00 |
| Mar 31, 2024 | 711,000.00 |
| Dec 31, 2023 | 237,000.00 |
| Dec 31, 2023 | 237,000.00 |
| Sep 30, 2023 | 238,000.00 |
| Sep 30, 2023 | 238,000.00 |
| Mar 31, 2023 | 688,000.00 |
| Mar 31, 2023 | 688,000.00 |